Abstract

As the Clinical Director of the Pediatric Oncology Branch I oversee the pediatric oncology clinical service at the NIH Clinical Center and have budgetary responsibility for and supervise the Branch clinical fellows, nurse practitioners, and patient care coordinator. I also direct the NCI fellowship training program in pediatric hematology/oncology, which is a joint training program with Johns Hopkins University. I supervise and mentor the 21 fellows in our Accreditation Council for Graduate Medical Education (ACGME)-accredited training program.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Clinical Training Intramural Research (ZIE)
Project #
1ZIEBC010764-05
Application #
8158448
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
5
Fiscal Year
2010
Total Cost
$3,204,829
Indirect Cost

  Institution

Name
National Cancer Institute Division of Basic Sciences
Department
Type
DUNS #
City
State
Country
Zip Code

  Publications

El-Mallawany, N K; Geller, L; Bollard, C M et al. (2011) Long-term remission in a child with refractory EBV(+) hydroa vacciniforme-like T-cell lymphoma through sequential matched EBV(+)-related allogeneic hematopoietic SCT followed by donor-derived EBV-specific cytotoxic T-lymphocyte immunotherapy. Bone Marrow Transplant 46:759-61
Dunleavy, Kieron; Little, Richard F; Pittaluga, Stefania et al. (2010) The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma. Blood 115:3017-24
Porter, David L; Alyea, Edwin P; Antin, Joseph H et al. (2010) NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 16:1467-503
Wayne, Alan S; Capitini, Christian M; Mackall, Crystal L (2010) Immunotherapy of childhood cancer: from biologic understanding to clinical application. Curr Opin Pediatr 22:2-11
Wayne, Alan S; Baird, Kristin; Egeler, R Maarten (2010) Hematopoietic stem cell transplantation for leukemia. Pediatr Clin North Am 57:1-25
Kroger, Nicolaus; Bacher, Ulrike; Bader, Peter et al. (2010) NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on disease-specific methods and strategies for monitoring relapse following allogenei Biol Blood Marrow Transplant 16:1325-46
Wayne, Alan S; Kreitman, Robert J; Findley, Harry W et al. (2010) Anti-CD22 immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-positive hematologic malignancies of childhood: preclinical studies and phase I clinical trial. Clin Cancer Res 16:1894-903
Capitini, Christian M; Mackall, Crystal L; Wayne, Alan S (2010) Immune-based therapeutics for pediatric cancer. Expert Opin Biol Ther 10:163-78
Bishop, Michael R; Alyea 3rd, Edwin P; Cairo, Mitchell S et al. (2010) Introduction to the reports from the National Cancer Institute First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 16:563-4
Kroger, Nicolaus; Bacher, Ulrike; Bader, Peter et al. (2010) NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogenei Biol Blood Marrow Transplant 16:1187-211

Showing the most recent 10 out of 14 publications